Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Earl Martin Douglas

General Counsel at Allogene Therapeutics, Inc. (ALLO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $103K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 25SEC ALLOAllogene Therapeutics, Inc. Sell 29,697488,267 held (−6%) $2.12 $63K -38.2%
Feb 4SEC ALLOAllogene Therapeutics, Inc. Sell 22,900564,948 held (−4%) $1.76 $40K -25.6%